246710.KQ KOE
T&R Biofab Co., Ltd.
1W: +1.3%
1M: +2.0%
3M: +6.4%
YTD: -29.7%
1Y: -23.4%
3Y: -79.2%
5Y: -89.2%
₩2,320.00 ($1.73)
+20.00 (+0.87%)
Weekly Expected Move ±6.0%
₩2040
₩2180
₩2320
₩2460
₩2600
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$7.5B
+36.4% ▲
Capital Expenditures
$2.1B
+23.6% ▲
5Y CAGR: -0.2%
Free Cash Flow
-$9.6B
+33.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$2M
+0.0% ▲
Net Change in Cash
-$16.7B
-368.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$70.1B | -$10.3B | -$13.4B | -$7.7B | -$34.9B |
| Depreciation & Amort. | $1.7B | $1.9B | $2.2B | $2.4B | $0 |
| Stock-Based Comp. | $722M | $3.6B | $1.1B | $792M | $0 |
| Change in Working Capital | -$698M | -$594M | $116M | -$3.3B | -$1.8B |
| Other Non-Cash Items | $75.5B | $195M | $3.1B | -$3.9B | $29.3B |
| Operating Cash Flow | -$7.6B | -$5.9B | -$7.0B | -$11.7B | -$7.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$9.0B | -$11.0B | -$12.5B | -$2.6B | -$2.4B |
| Acquisitions (Net) | $0 | $0 | $0 | -$6.5B | $0 |
| Investment Purchases | -$51.4B | -$75.6B | -$64.5B | -$27.5B | $0 |
| Investment Sales | $28.3B | $104.0B | $39.5B | $50.2B | $0 |
| Other Investing | -$1.7B | $163M | -$20M | -$2.0B | $4.1B |
| Investing Cash Flow | -$33.8B | $17.6B | -$37.5B | $11.7B | $1.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | $41.2B | -$890M | $28.5B | -$7.3B | -$24.1B |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$2M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$587M | $83M | -$940M | -$1.0B | -$1.2B |
| Financing Cash Flow | $41.7B | -$219M | $29.6B | -$3.5B | -$3.2B |
| Net Change in Cash | $386M | $11.5B | -$14.9B | -$3.6B | -$16.7B |
| Cash End of Period | $23.7B | $35.1B | $20.2B | $16.7B | $0 |
| Free Cash Flow | -$16.6B | -$16.9B | -$19.7B | -$14.5B | -$9.6B |